A Multistage Genetic Association Study Identifies Breast Cancer Risk Loci at 10q25 and 16q24

Background: Heritable risk for breast cancer includes an increasing number of common, low effect risk variants. We conducted a multistage genetic association study in a series of independent epidemiologic breast cancer study populations to identify novel breast cancer risk variants. Methods: We tested 1,162 SNPs of greatest nominal significance from stage I of the Cancer Genetic Markers of Susceptibility breast cancer study (CGEMS; 1,145 cases, 1,142 controls) for evidence of replicated association with breast cancer in the Nashville Breast Cohort (NBC; 599 cases, 1,161 controls), the Collaborative Breast Cancer Study (CBCS; 1,552 cases, 1,185 controls), and BioVU Breast Cancer Study (BioVU; 1,172 cases, 1,172 controls). Results: Among these SNPs, a series of validated breast cancer risk variants yielded expected associations in the study populations. In addition, we observed two previously unreported loci that were significantly associated with breast cancer risk in the CGEMS, NBC, and CBCS study populations and had a consistent, although not statistically significant, risk effect in the BioVU study population. These were rs1626678 at 10q25.3 near ENO4 and KIAA1598 (meta-analysis age-adjusted OR = 1.13 [1.07–1.20], P = 5.6 × 10−5), and rs8046508 at 16q23.1 in the eighth intron of WWOX (meta-analysis age-adjusted OR = 1.20 [1.10–1.31], P = 3.5 × 10−5). Conclusions: Our data supports the association of two novel loci, at 10q25.3 and 16q23.1, with risk of breast cancer. Impact: The expanding compendium of known breast cancer genetic risk variants holds increasing power for clinical risk prediction models of breast cancer, improving upon the Gail model. Cancer Epidemiol Biomarkers Prev; 21(9); 1565–73. ©2012 AACR.

[1]  N. Dalay,et al.  Genetic alterations of the WWOX gene in breast cancer , 2012, Medical Oncology.

[2]  Jane E. Carpenter,et al.  A common variant at the TERT-CLPTM1L locus is associated with estrogen receptor–negative breast cancer , 2011, Nature Genetics.

[3]  J. Barrett,et al.  Genetic risk prediction in complex disease , 2011, Human molecular genetics.

[4]  Joan P Breyer,et al.  A multistage association study identifies a breast cancer genetic locus at NCOA7. , 2011, Cancer research.

[5]  M. Capello,et al.  α‐enolase: a promising therapeutic and diagnostic tumor target , 2011, The FEBS journal.

[6]  Michael Jones,et al.  Novel breast cancer susceptibility locus at 9q31.2: results of a genome-wide association study. , 2011, Journal of the National Cancer Institute.

[7]  David A. Hinds,et al.  Assessment of Clinical Validity of a Breast Cancer Risk Model Combining Genetic and Clinical Information , 2010, Journal of the National Cancer Institute.

[8]  D. Galileo,et al.  Soluble L 1 CAM promotes breast cancer cell adhesion and migration in vitro , but not invasion , 2010 .

[9]  A. Jemal,et al.  Cancer Statistics, 2010 , 2010, CA: a cancer journal for clinicians.

[10]  M. Adams,et al.  Confirmation of linkage to and localization of familial colon cancer risk haplotype on chromosome 9q22. , 2010, Cancer research.

[11]  Deborah Hughes,et al.  Genome-wide association study identifies five new breast cancer susceptibility loci , 2010, Nature Genetics.

[12]  Montserrat Garcia-Closas,et al.  Genetic susceptibility to breast cancer , 2010, Molecular oncology.

[13]  Melissa A. Basford,et al.  Robust replication of genotype-phenotype associations across multiple diseases in an electronic medical record. , 2010, American journal of human genetics.

[14]  Peter Kraft,et al.  A Genome-Wide Association Study of Prognosis in Breast Cancer , 2010, Cancer Epidemiology, Biomarkers & Prevention.

[15]  M. Thun,et al.  Performance of Common Genetic Variants in Breast-cancer Risk Models , 2022 .

[16]  Kevin P. Claffey,et al.  Differential protein expression profiles in estrogen receptor-positive and -negative breast cancer tissues using label-free quantitative proteomics. , 2010, Genes & cancer.

[17]  Kevin M. Bradley,et al.  Protein phosphatase 2A subunit gene haplotypes and proliferative breast disease modify breast cancer risk , 2009, Cancer.

[18]  R. Aqeilan,et al.  WWOX: Its genomics, partners, and functions , 2009, Journal of cellular biochemistry.

[19]  Giovanni Parmigiani,et al.  Inactivating germ-line and somatic mutations in polypeptide N-acetylgalactosaminyltransferase 12 in human colon cancers , 2009, Proceedings of the National Academy of Sciences.

[20]  F. Collins,et al.  Potential etiologic and functional implications of genome-wide association loci for human diseases and traits , 2009, Proceedings of the National Academy of Sciences.

[21]  M. Thun,et al.  Newly discovered breast cancer susceptibility loci on 3p24 and 17q23.2 , 2009, Nature Genetics.

[22]  W. Willett,et al.  A multistage genome-wide association study in breast cancer identifies two new risk alleles at 1p11.2 and 14q24.1 (RAD51L1) , 2009, Nature Genetics.

[23]  B. Browning,et al.  A unified approach to genotype imputation and haplotype-phase inference for large data sets of trios and unrelated individuals. , 2009, American journal of human genetics.

[24]  Tadao Sugiura,et al.  Shootin1 interacts with actin retrograde flow and L1-CAM to promote axon outgrowth , 2008, Neuroscience Research.

[25]  S. Chanock,et al.  Genetic Susceptibility Loci for Breast Cancer by Estrogen Receptor Status , 2008, Clinical Cancer Research.

[26]  Chun Li,et al.  Assessing departure from Hardy‐Weinberg equilibrium in the presence of disease association , 2008, Genetic epidemiology.

[27]  D. Roden,et al.  Development of a Large‐Scale De‐Identified DNA Biobank to Enable Personalized Medicine , 2008, Clinical pharmacology and therapeutics.

[28]  M. Gail.  Discriminatory accuracy from single-nucleotide polymorphisms in models to predict breast cancer risk. , 2008, Journal of the National Cancer Institute.

[29]  A. Sigurdsson,et al.  Common variants on chromosome 5p12 confer susceptibility to estrogen receptor–positive breast cancer , 2008, Nature Genetics.

[30]  Douglas G. Altman,et al.  Metan: Fixed- and Random-Effects Meta-Analysis , 2008 .

[31]  D. Gudbjartsson,et al.  Common variants on chromosomes 2q35 and 16q12 confer susceptibility to estrogen receptor–positive breast cancer , 2007, Nature Genetics.

[32]  Lester L. Peters,et al.  Genome-wide association study identifies novel breast cancer susceptibility loci , 2007, Nature.

[33]  W. Willett,et al.  A genome-wide association study identifies alleles in FGFR2 associated with risk of sporadic postmenopausal breast cancer , 2007, Nature Genetics.

[34]  V. Pantesco,et al.  A Meta‐Analysis of Human Embryonic Stem Cells Transcriptome Integrated into a Web‐Based Expression Atlas , 2007, Stem cells.

[35]  I. Brockhausen,et al.  Mucin‐type O‐glycans in human colon and breast cancer: glycodynamics and functions , 2006, EMBO reports.

[36]  S. Chanock,et al.  Genetic Polymorphisms in Base-Excision Repair Pathway Genes and Risk of Breast Cancer , 2006, Cancer Epidemiology Biomarkers & Prevention.

[37]  D. Amadori,et al.  WWOX gene restoration prevents lung cancer growth in vitro and in vivo , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[38]  V Shane Pankratz,et al.  Benign breast disease and the risk of breast cancer. , 2005, The New England journal of medicine.

[39]  Jacqueline K. Wittke-Thompson,et al.  Rational inferences about departures from Hardy-Weinberg equilibrium. , 2005, American journal of human genetics.

[40]  Dimitrios Iliopoulos,et al.  Fragile genes as biomarkers: epigenetic control of WWOX and FHIT in lung, breast and bladder cancer , 2005, Oncogene.

[41]  K. Tachibana,et al.  Molecular cloning and characterization of a novel member of the UDP‐GalNAc:polypeptide N‐acetylgalactosaminyltransferase family, pp‐GalNAc‐T12 1 , 2002 .

[42]  K. Tachibana,et al.  Molecular cloning and characterization of a novel member of the UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase family, pp-GalNAc-T12. , 2002, FEBS letters.

[43]  A. Brenner,et al.  WWOX, the FRA16D gene, behaves as a suppressor of tumor growth. , 2001, Cancer research.

[44]  A. Bednarek,et al.  WWOX, a novel WW domain-containing protein mapping to human chromosome 16q23.3-24.1, a region frequently affected in breast cancer. , 2000, Cancer research.

[45]  P. Fernández,et al.  Phosphoglycerate mutase, 2,3-bisphosphoglycerate phosphatase, creatine kinase and enolase activity and isoenzymes in breast carcinoma , 1999, British Journal of Cancer.

[46]  M. Ehm,et al.  Detecting marker-disease association by testing for Hardy-Weinberg disequilibrium at a marker locus. , 1998, American journal of human genetics.

[47]  G. Colditz,et al.  A prospective study of benign breast disease and the risk of breast cancer , 1992, JAMA.

[48]  M. Gail,et al.  Projecting individualized probabilities of developing breast cancer for white females who are being examined annually. , 1989, Journal of the National Cancer Institute.

[49]  N. Dubrawsky.  Cancer statistics , 1989, CA: a cancer journal for clinicians.

[50]  E. DeLong,et al.  Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. , 1988, Biometrics.

[51]  W D Dupont,et al.  Risk factors for breast cancer in women with proliferative breast disease. , 1985, The New England journal of medicine.

[52]  J. Grootegoed,et al.  A sperm-specific enolase. , 1983, Journal of reproduction and fertility.

[53]  Hu Shih,et al.  Development of Methodology , 1980 .